Anti-Complement component C9a antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | Complement component C9a |
| Immunogen: | KLH conjugated synthetic peptide derived from human Complement component C9a 161-260/559 |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:500-1:2000); Flow Cytometry (3ug/Test) |
| Reactivity: | Human |
| Clonality (clone number): | Polyclonal |
| Form: | Liquid |
| Buffer: | 10mM Tris-HCl buffer (pH7.4), 1% BSA, 50% glycerol, 0.03% Proclin300. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | C9a, C9 deficiency |
| C9a | |
| C9 deficiency with dermatomyositis | |
| CO9_HUMAN | |
| Complement component 9 | |
| Complement component 9 deficiency | |
| Complement component C9a | |
| Complement component C9a |
Show More
Target information
Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells (PubMed:9634479, PubMed:9212048, PubMed:26841934). C9 is the pore-forming subunit of the MAC (PubMed:4055801, PubMed:26841934, PubMed:30111885).
Provider
Erpantech Laboratory